CDC73 and malignant tumor of parathyroid gland: Given the strong evidence linking inactivation of HRPT2/CDC73 gene and malignant parathyroid tumor, gene mutations screening and detection of parafibromin immunoreactivity have been suggested as diagnostic instruments of PC.